Novel outcomes in inflammatory bowel disease - Takeaways - MDSpire

Novel outcomes in inflammatory bowel disease

  • By

  • Vipul Jairath

  • Neeraj Narula

  • Ryan C Ungaro

  • Itzel Romo Bautista

  • Shashi Adsul

  • March 13, 2025

  • 0 min

Share

  • 1

    Inflammatory bowel diseases (IBD), including Crohn’s disease and ulcerative colitis, are chronic conditions with increasing global prevalence.

  • 2

    Effective management of IBD requires both short- and long-term treatment goals, focusing on symptom relief and mucosal healing.

  • 3

    Biologic and small molecule therapies target the underlying pathophysiology of IBD, offering potential for disease modification.

  • 4

    Recent trials indicate that early combination therapy may reduce complications more effectively than traditional symptom-based management.

  • 5

    Novel endpoints, including patient-reported outcomes and histological healing, are being explored to better assess treatment efficacy in IBD.

Original Source(s)

Novel outcomes in inflammatory bowel disease

  • by Vipul Jairath, Neeraj Narula, Ryan C Ungaro, Itzel Romo Bautista, Shashi Adsul

  • March 13, 2025

Related Content

REACHing forward—a strategic vision for ECCO and the future of IBD care

AMA Backs Structured Vaccine Review

Medical societies and public health groups will collaborate on policy questions and evidence briefs for the 2026 to 2027 respiratory virus season.

Advanced Crohn’s Therapies Show Similar Safety

Large claims analysis finds no significant differences in serious infections, blood clots, or major cardiovascular events across biologics and a Janus kinase inhibitor.